| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,1
* Department of Developmental Biology, Harvard School of Dental Medicine, Boston, Massachusetts, USA;
Department of Pathology, Harvard Medical School, Boston, Massachusetts, USA;
Department of Pathology, Nagasaki University School of Biomedical Sciences, Nagasaki, Japan; and
Department of Pharmacology, New York University School of Medicine, New York, New York, USA.
1Correspondence: Department of Developmental Biology, Harvard School of Dental Medicine, Rm.: 304, 188 Longwood Ave., Boston, MA 02115, USA. E-mail: mrazzaque{at}hms.harvard.edu or razzaquems{at}yahoo.com
A major breakthrough in systemic phosphate homeostasis regulation was achieved by the demonstration of strikingly similar physical, morphological, and biochemical phenotypes of fibroblast growth factor 23 (Fgf23) and klotho ablated mice, which led to identification of klotho as an Fgf23 signaling cofactor. Here, we generated Fgf23 and klotho double-knockout (Fgf23–/–/klotho–/–) mice to test the hypothesis whether Fgf23 has a klotho-independent function. Fgf23–/–/klotho–/– mice are viable and have high serum phosphate levels, similar to Fgf23–/– and klotho–/– single-knockout mice. In addition, the Fgf23–/–/klotho–/– mice have increased renal expression of the sodium/phosphate cotransporter NaPi2a and of 1- alpha-hydroxylase concomitant with increased serum levels of 1,25-dihydroxyvitamin-D, as also observed in the Fgf23–/– and klotho–/– mice. Moreover, Fgf23–/–/klotho–/– mice show soft tissue and vascular calcification, severe muscle wasting, hypogonadism, pulmonary emphysema, distention of intestinal wall, and skin atrophy, all of which are also seen in Fgf23–/– and klotho–/– mice. Notably, injection of bioactive FGF23 protein into Fgf23–/–/klotho–/– and klotho–/– mice does not lower serum phosphate, whereas in wild-type and Fgf23–/– mice, it reduces serum phosphate. Together, these results provide compelling evidence that Fgf23 does not have a klotho-independent role in the regulation of systemic phosphate and vitamin D homeostasis.—Nakatani, T., Sarraj, B., Ohnishi, M., Densmore, M. J., Taguchi, T., Goetz, R., Mohammadi, M., Lanske, B., Razzaque, M. S. In vivo genetic evidence for klotho-dependent, fibroblast growth factor 23 (Fgf23) -mediated regulation of systemic phosphate homeostasis.
Key Words: kidney • vitamin D • PTH • NaPi2a • calcification • survival
This article has been cited by other articles:
|
|
 |
|
  M. Ohnishi, T. Nakatani, B. Lanske, and M. S. Razzaque In Vivo Genetic Evidence for Suppressing Vascular and Soft-Tissue Calcification Through the Reduction of Serum Phosphate Levels, Even in the Presence of High Serum Calcium and 1,25-Dihydroxyvitamin D Levels Circ Cardiovasc Genet, December 1, 2009; 2(6): 583 - 590. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Nakatani, M. Ohnishi, and M. S. Razzaque Inactivation of klotho function induces hyperphosphatemia even in presence of high serum fibroblast growth factor 23 levels in a genetically engineered hypophosphatemic (Hyp) mouse model FASEB J, November 1, 2009; 23(11): 3702 - 3711. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. T. Alexander, T. E. Woudenberg-Vrenken, J. Buurman, H. Dijkman, B. C. J. van der Eerden, J. P.T.M. van Leeuwen, R. J. Bindels, and J. G. Hoenderop Klotho Prevents Renal Calcium Loss J. Am. Soc. Nephrol., November 1, 2009; 20(11): 2371 - 2379. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Carrillo-Lopez, P. Roman-Garcia, A. Rodriguez-Rebollar, J. L. Fernandez-Martin, M. Naves-Diaz, and J. B. Cannata-Andia Indirect Regulation of PTH by Estrogens May Require FGF23 J. Am. Soc. Nephrol., September 1, 2009; 20(9): 2009 - 2017. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Razzaque FGF23-mediated regulation of systemic phosphate homeostasis: is Klotho an essential player? Am J Physiol Renal Physiol, March 1, 2009; 296(3): F470 - F476. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
